PLX

Protalix Biother

• TipRanks·04/02 00:28

  Protalix Earnings Call: EU Win, Cash Boost, Trade-Offs

• Seeking Alpha·03/24 18:42

  Protalix Revenue Miss Overshadowed By Milestone-Backed 2026 Guidance

• Dow Jones·03/19 12:25

  Protalix BioTherapeutics Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

• Benzinga·03/19 12:15

  HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target

• TipRanks·03/19 10:25

  Protalix: EU Approval and Commercial Tailwinds for Elfabrio Underscore Undervalued Upside

• NASDAQ·03/19 01:19

  Protalix Stock Down As FY25 Results Show Net Loss, Fabry Milestones Boosts Outlook

• Benzinga·03/18 17:06

  12 Health Care Stocks Moving In Wednesday's Intraday Session

• NASDAQ·03/18 15:59

  Wednesday Sector Laggards: Precious Metals, Biotechnology Stocks

• Seeking Alpha·03/18 14:13

  Protalix targets $78M–$83M 2026 revenue with EU milestone, advancing PRX-115

• Benzinga·03/18 11:11

  Earnings Scheduled For March 18, 2026

• Benzinga·03/18 11:01

  Protalix BioTherapeutics Expects FY26 Total Revenue To Range From ~$78M To $83M Including $25M Milestone Which Protalix Is Entitled To From Chiesi

• Benzinga·03/18 10:57

  Protalix BioTherapeutics Q4 EPS $(0.06) Misses $0.04 Estimate, Sales $9.300M Miss $16.918M Estimate

• Seeking Alpha·03/18 10:54

  Protalix BioTherapeutics misses top-line and bottom-line estimates; gives FY26 outlook

• PR Newswire·03/18 10:50

  Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results

• Seeking Alpha·03/17 22:00

  Here are the major earnings before the open Wednesday